Medicine details

ImageGaboton 300
NameGaboton 300
DosageTablet
Generic NameGabapentin
Classes Central Nervous System Agent
Anticonvulsant / Antiepileptic Agent
Psychotherapeutic Agent
GABA Analogue
Diseases CNS Disorder
Seizure
Shingles
CompanyNovartis (Bangladesh) Ltd.

Drug Package Details

Strength300 mg
Storage Condition
Origin CountryBangladesh
Commercial Pack30
Price per pack480.00
Cost per pack422.40
Package unit10 tabs strip
Price per unit16.00
Cost per unit14.08
Discount0
Coupon
Remarks

Gabapentin

Gabapentin belongs to a class of drugs called the anticonvulsants. It is unknown exactly how gabapentin produces its analgesic and antiepileptic effects. Gabapentin has a similar structure to the neurotransmitter gamma-aminobutyric acid (GABA), but it has no effect on GABA binding, uptake, or degradation. In vitro studies have shown that gabapentin binds to the 2 subunit of voltage-activated calcium channels with high affinity; however, the relationship of this binding to gabapentin's therapeutic effects is unknown.

 

Gabapentin is indicated for:

  • Postherpetic neuralgia in adults
  • Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy

 

Postherpetic Neuralgia 

  • Dose can be titrated up as needed to a dose of 1800 mg/day 
  • Day 1: Single 300 mg dose 
  • Day 2: 600 mg/day (i.e., 300 mg two times a day)
  • Day 3: 900 mg/day (i.e., 300 mg three times a day)

Epilepsy with Partial Onset Seizures 

  • Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily 
  • Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days 
  • Dose should be adjusted in patients with reduced renal function

 

Most common adverse reactions were: 

  • Postherpetic neuralgia: Dizziness, somnolence, and peripheral edema 
  • Epilepsy in patients >12 years of age: Somnolence, dizziness, ataxia, fatigue, and nystagmus 
  • Epilepsy in patients 3 to 12 years of age: Viral infection, fever, nausea and/or vomiting, somnolence, and hostility

 

  • Drug Reaction with Eosinophilia and Systemic Symptoms (Multiorgan hypersensitivity):  If an alternative etiology cannot be established, the treatment should be discontinued.
  • Anaphylaxis and Angioedema: Stop immediately and evaluate the patient.
  • If Gabapentin is abruptly discontinued, patients with seizure disorders may experience an increase in seizure frequency.
  • Driving Impairment; Somnolence/Sedation and Dizziness: Warn patients not to drive until they have gained sufficient experience to assess whether their ability to drive or operate heavy machinery will be impaired
  • Suicidal Behavior and Ideation: Suicidal thoughts/behavior should be monitored.

 

Contraindication

Contraindicated in patients with known hypersensitivity to gabapentin.